Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11439610
Compositions and methods for enhancing the efficacy of contraceptive microbicides
granted -
US 11440943
Therapeutic interferon alpha 1 proteins
granted -
US 11441184
Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)
granted -
US 11439590
Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
granted -
US 11439615
Lipoxin and lipoxin analogue mediated neuroprotection and treatments
granted -
US 11440951
Therapeutic antibodies to Marburg virus
granted -
US 11439725
Bioresorbable embolization microspheres
granted -
US 11439695
Kidney injury treatment
granted -
US 11439708
Nanotube trans-membrane channels mimicking biological porins
granted -
US 11440883
Heterocyclic compound and use thereof
granted -
US 11439683
Anti-angiogenic therapy of metastatic colorectal cancer
granted -
US 11439709
Phospholipid ether analogs as cancer-targeting drug vehicles
granted -
US 11439629
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11439659
Methods and compositions to prevent and treat inflammation and allergic reactions
granted -
US 11439609
Nitric oxide releasing PLGA microspheres for biomedical applications
granted -
US 11440939
Anticancer peptides
granted -
US 11439658
Compositions and methods for suppressing MSUT2
granted -
US 11439632
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 11439635
B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoholic fatty liver disease
granted -
US 11439669
C. novyi for the treatment of solid tumors in humans
granted -
US 11439611
Administration of serine protease inhibitors to the stomach
granted -
US 11440885
Substituted 1-arylalkyl-4-acylaminopiperidine compounds and methods of producing and using the same
granted -
US 11439656
Pharmaceutical compounds and uses thereof
granted -
US 11439641
Pyrimidine JAK inhibitors for the treatment of skin diseases
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.